We previously reported that the genetic status of Notch2 has predictive value for GBM survival [10] and patients with high levels of Notch3 have a significantly shorter overall survival (OS) expectancy in the REMBRANDT data set. The gene discussed is NOTCH2; the disease is glioblastoma.